The market has dropped by 13% in the last 7 days, yet it has risen by 13% over the past year, with earnings forecasted to grow by 17% annually. In this fluctuating environment, identifying growth stocks with high insider ownership can provide insights into companies where those closest to the business have strong confidence in its future potential.
| Name | Insider Ownership | Earnings Growth |
| Uxin (UXIN) | 34.3% | 69.4% |
| Upstart Holdings (UPST) | 13.9% | 68.4% |
| Precigen (PGEN) | 11.7% | 55.4% |
| Nu Holdings (NU) | 22.8% | 21.8% |
| Karman Holdings (KRMN) | 14.4% | 54% |
| Hinge Health (HNGE) | 15.6% | 27.6% |
| Himax Technologies (HIMX) | 29.2% | 70.2% |
| Dave (DAVE) | 16.9% | 23.2% |
| Carlyle Group (CG) | 27.5% | 20.5% |
| Almonty Industries (ALM) | 10.8% | 38% |
Here's a peek at a few of the choices from the screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Oddity Tech Ltd. is a consumer tech company that creates digital-first brands in the beauty and wellness sectors across the United States, Israel, and internationally, with a market cap of $737.07 million.
Operations: The company generates revenue from its Personal Products segment, which amounted to $679.09 million.
Insider Ownership: 26.7%
Earnings Growth Forecast: 39.8% p.a.
Oddity Tech exhibits significant earnings growth potential, with forecasts of 39.8% annually over the next three years, outpacing the US market. However, recent financial results show a decline in sales and net income compared to last year. Despite being volatile and trading below estimated fair value, insider activity shows substantial selling recently. The company has completed a significant share buyback program and anticipates further revenue declines for 2026 while maintaining high insider ownership levels.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Clover Health Investments, Corp. offers Medicare Advantage plans in the United States and has a market cap of $2.31 billion.
Operations: The company generates revenue from its Medicare Advantage insurance segment, totaling $2.48 billion.
Insider Ownership: 21.6%
Earnings Growth Forecast: 45.7% p.a.
Clover Health Investments shows strong growth potential, with earnings forecasted to grow 45.67% annually and revenue expected to rise faster than the US market at 13.9% per year. Recent financials reveal improved performance, with Q2 revenue at US$743.17 million and net income of US$28 million, contrasting a prior loss. Despite significant insider selling recently, the company raised its full-year revenue guidance to between US$2.92 billion and US$3 billion, reflecting positive momentum amid management changes.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Warby Parker Inc. operates as a retailer of eyewear products through both physical stores and an online platform in the United States and Canada, with a market capitalization of approximately $3.04 billion.
Operations: The company's revenue is primarily derived from its Holistic Vision Care segment, which generated $911.61 million.
Insider Ownership: 13.4%
Earnings Growth Forecast: 76.2% p.a.
Warby Parker's growth trajectory is underscored by its recent profitability, with Q2 2026 net income at US$4.64 million compared to a loss last year. Earnings are projected to grow significantly at 76.18% annually, outpacing the US market average. Despite substantial insider selling recently, revenue is expected to grow faster than the market at 18.4% per year. The company reaffirmed its full-year guidance, projecting net revenue between US$959 million and US$976 million for fiscal 2026.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com